Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
Autonomix Medical announced positive feedback from the FDA indicating a potential Class II 510(k) clearance pathway leveraging substantial equivalence to an already-cleared device for its standalone transvascular sensing platform. The company targets U.S. clearance in approximately 15 months, which marks a significant step toward commercializing it…